Literature DB >> 28488363

The role of regulatory T cells in nervous system pathologies.

Samuel S Duffy1, Brooke A Keating1, Chamini J Perera1, Gila Moalem-Taylor1.   

Abstract

Regulatory T (Treg) cells are a special subpopulation of immunosuppressive T cells that are essential for sustaining immune homeostasis. They maintain self-tolerance, inhibit autoimmunity, and act as critical negative regulators of inflammation in various pathological states including autoimmunity, injury, and degeneration of the nervous system. Treg cells are known to convey both beneficial and detrimental influences in certain disease contexts, and accumulating research suggests that their action may be altered in a range of peripheral and central nervous system pathologies. In this review, we discuss emerging evidence for the dichotomous role of Treg cells in various neurological pathologies including multiple sclerosis, Guillain-Barré syndrome, neuropathic pain, traumatic central nervous system injury, stroke, and neurodegenerative diseases such as amyotrophic lateral sclerosis, Alzheimer's disease, and Parkinson's disease. We are in the early stages of uncovering the role of Treg cells in these conditions, and a better understanding of the ways in which these cells operate in the nervous system will enable us to develop novel therapeutic interventions.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  T cells; nervous system; neuroimmunology; neuroinflammation

Mesh:

Year:  2017        PMID: 28488363     DOI: 10.1002/jnr.24073

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  18 in total

1.  Granulocyte-macrophage colony-stimulating factor neuroprotective activities in Alzheimer's disease mice.

Authors:  Tomomi Kiyota; Jatin Machhi; Yaman Lu; Bhagyalaxmi Dyavarshetty; Maryam Nemati; Izumi Yokoyama; R L Mosley; Howard E Gendelman
Journal:  J Neuroimmunol       Date:  2018-03-17       Impact factor: 3.478

2.  Regulatory T Cells and Their Derived Cytokine, Interleukin-35, Reduce Pain in Experimental Autoimmune Encephalomyelitis.

Authors:  Samuel S Duffy; Brooke A Keating; Chamini J Perera; Justin G Lees; Ryan S Tonkin; Preet G S Makker; Pascal Carrive; Oleg Butovsky; Gila Moalem-Taylor
Journal:  J Neurosci       Date:  2019-01-16       Impact factor: 6.167

3.  Interleukin-10 Modulation of Virus Clearance and Disease in Mice with Alphaviral Encephalomyelitis.

Authors:  Nina M Martin; Diane E Griffin
Journal:  J Virol       Date:  2018-02-26       Impact factor: 5.103

Review 4.  Regulatory T cells in ischemic stroke.

Authors:  Hong-Yun Wang; Jun-Rui Ye; Li-Yuan Cui; Shi-Feng Chu; Nai-Hong Chen
Journal:  Acta Pharmacol Sin       Date:  2021-03-26       Impact factor: 6.150

Review 5.  Thrombo-Inflammation and Immunological Response in Ischemic Stroke: Focusing on Platelet-Tregs Interaction.

Authors:  Jieqiong Cui; Huayan Li; Zongning Chen; Ting Dong; Xiying He; Yuanyuan Wei; Zhengkun Li; Jinfeng Duan; Ting Cao; Qian Chen; Dongmei Ma; Yang Zhou; Bo Wang; Mingqin Shi; Qin Zhang; Lei Xiong; Dongdong Qin
Journal:  Front Cell Neurosci       Date:  2022-06-29       Impact factor: 6.147

Review 6.  T Lymphocytes in Parkinson's Disease.

Authors:  Elena Contaldi; Luca Magistrelli; Cristoforo Comi
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

7.  Regulation of Th17/Treg Balance by 27-Hydroxycholesterol and 24S-Hydroxycholesterol Correlates with Learning and Memory Ability in Mice.

Authors:  Tao Wang; Shanshan Cui; Ling Hao; Wen Liu; Lijing Wang; Mengwei Ju; Wenjing Feng; Rong Xiao
Journal:  Int J Mol Sci       Date:  2022-04-15       Impact factor: 6.208

8.  A Synthetic Agonist to Vasoactive Intestinal Peptide Receptor-2 Induces Regulatory T Cell Neuroprotective Activities in Models of Parkinson's Disease.

Authors:  R Lee Mosley; Yaman Lu; Katherine E Olson; Jatin Machhi; Wenhui Yan; Krista L Namminga; Jenell R Smith; Scott J Shandler; Howard E Gendelman
Journal:  Front Cell Neurosci       Date:  2019-09-18       Impact factor: 5.505

Review 9.  Harnessing regulatory T cell neuroprotective activities for treatment of neurodegenerative disorders.

Authors:  Jatin Machhi; Bhavesh D Kevadiya; Ijaz Khan Muhammad; Jonathan Herskovitz; Katherine E Olson; R Lee Mosley; Howard E Gendelman
Journal:  Mol Neurodegener       Date:  2020-06-05       Impact factor: 14.195

10.  Influenza vaccination in early Alzheimer's disease rescues amyloidosis and ameliorates cognitive deficits in APP/PS1 mice by inhibiting regulatory T cells.

Authors:  Yunjie Yang; Zitian He; Zhiwei Xing; Zejie Zuo; Lifang Yuan; Yingying Wu; Mei Jiang; Fangfang Qi; Zhibin Yao
Journal:  J Neuroinflammation       Date:  2020-02-19       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.